The Global Inflation Devices Market size is expected to reach $656.6 Million by 2025, rising at a market growth of 4% CAGR during the forecast period. Inflation devices are used to fill and empty balloons for surgical procedures. Inflation devices work by creating a certain preset limit to the atmospheric pressure. It shows the amount of pressure applied to the device. These systems may have various display types, such as analog displays and digital displays.
Due to their luminescent backgrounds, these devices have different properties, such as the digital displays provide an advantage in noting the readings in a dim light environment. In addition, analog displays are user-friendly and easy to use, as they are integrated with a scale that shows the readings. Moreover, these devices are used in specific surgeries such as gastroenterological procedures and cardiovascular procedures.
The growth of the global demand for inflation devices led by the increase in the adoption of minimally invasive procedures, these surgical procedures; for example, involve smaller incisions resulting in less scarring. Such operations are often less painful compared with treatments requiring wider incisions. In addition, these procedures often have a higher precision rate relative to conventional open surgery.
The growing acceptance of minimally invasive procedures, the emergence of advanced healthcare facilities in a majority of developing countries, the rising prevalence of CVD and the less rigorous approval procedures lead to market development. The severity of coronary artery disease is also anticipated to increase with the growth of the geriatric population, which is a major target indicator for interventional cardiology procedures that use an inflation device to inflate and deflate the balloon. These primary factors are expected to fuel market growth over the forecast period.
Based on Application, the market is segmented into Interventional Cardiology & Radiology, Urological Procedures, Peripheral Vascular Procedures and Gastroenterological Procedures. Based on Display Type, the market is segmented into Analogue Inflation Devices and Digital Inflation Devices. Based on End User, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Centers. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson (Acclarent, Inc.), Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., ConMed Corporation, Cook Medical, Inc. (Cook Group), Medtronic PLC, Olympus Corporation, Teleflex, Inc., and Terumo Corporation.
Strategies deployed in Inflation Devices Market
Jan-2020: Cook Medical introduced the TriForce Peripheral Crossing Set. These set helps the physicians in procedures to treat patients with vascular obstructions.
Dec-2019: BD completed the acquisition of C. R. Bard Inc., a medical technology developer in the fields of vascular, urology, oncology and surgical specialty products. The acquisition broadened the product portfolio of BD.
Jun-2019: Terumo came into partnership with Orchestra BioMed Inc., a therapeutic device company. The partnership was aimed at developing and commercializing the Virtue Sirolimus-Eluting Balloon (SEB), one of Orchestra’s lead assets, in the percutaneous coronary and peripheral interventions field.
Apr-2019: BD released the UltraScore 014 Focused Force PTA Balloon. The balloon is intended to dilate stenoses in the iliac, femoral, ilio-femoral, popliteal, infra-popliteal and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.
Feb-2018: Terumo signed an agreement with Capgemini, a technology outsourcing services firm. The agreement was focused on developing two global innovation and development centres in India. The centres would develop next-generation device platforms for Terumo’s blood component business entity Terumo BCT, a global leader in blood component, therapeutic apheresis, and cellular technologies.
May-2017: Teleflex launched the new Arrow AC3 Optimus intra-aortic balloon (IABP). This system has been designed for helping a weakened heart pump blood and it can provide IABP therapy to a broad range of patients, even those not previously considered candidates for IABP therapy.
Scope of the Study
• Interventional Cardiology & Radiology
• Urological Procedures
• Peripheral Vascular Procedures and
• Gastroenterological Procedures
By Display Type
• Analogue Inflation Devices and
• Digital Inflation Devices
By End User
• Hospitals & Clinics and
• Ambulatory Surgical Centers
• North America
o Rest of North America
o Rest of Europe
• Asia Pacific
o South Korea
o Rest of Asia Pacific
o Saudi Arabia
o South Africa
o Rest of LAMEA
• Johnson and Johnson (Acclarent, Inc.)
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Cardinal Health, Inc.
• ConMed Corporation
• Cook Medical, Inc. (Cook Group)
• Medtronic PLC
• Olympus Corporation
• Teleflex, Inc.
• Terumo Corporation
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
Our reports have been used by over 10K customers, including:
The global hospital EMR systems market is projected to reach USD 20.7 billion by 2025 from USD 14.2 billion in 2020, at a CAGR of 7.8% during the forecast period. There is a growing inclination across the globe towards the adoption of EMR systems due to government support for the adoption of EMRs, an increase in the COVID-19 patient volume,...
Patient Handling Equipment Market Research Report by Product (Ambulatory Aids, Bathroom Safety Supplies, Mechanical Equipment, Medical Beds, and Non-mechanical Equipment), by Type of Care (Bariatric Care, Critical Care, Fall Prevention, and Wound Care), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 The...
Cardiac Ablation Market Research Report by Type (Catheter Ablation, Hybrid Surgical-catheter Ablation, and Surgical Ablation), by Application (Cardiac Rhythm Management and Open Surgery), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Cardiac Ablation Market is expected to grow from...
142 pages •
By Global Industry Analysts
• Jul 2020
Global Patient Handling Equipment Market to Reach US$25.3 Billion by the Year 2027 Amid the COVID-19 crisis, the global market for Patient Handling Equipment estimated at US$13.7 Billion in the year 2020, is projected to reach a revised size of US$25.3 Billion by 2027, growing at a CAGR of 9.2% over the analysis period 2020-2027.Wheelchair...
225 pages •
By Global Industry Analysts
• Jul 2020
Global Breast Surgery Retractors Market to Reach US$326.1 Million by the Year 2027 Amid the COVID-19 crisis, the global market for Breast Surgery Retractors estimated at US$265 Million in the year 2020, is projected to reach a revised size of US$326.1 Million by 2027, growing at a CAGR of 3% over the period 2020-2027.Single-Arm Retractors,...
321 pages •
By The Business Research Company
• Jul 2020
Database Software Global Market Opportunities And Strategies To 2030: COVID 19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global Database Software market. Description: Where is the largest and fastest growing market for the Database...
The Asia Pacific breast cancer screening was valued at US$ 798.57 million in 2019 and is projected to reach US$ 1,120.77 million by 2027; it is expected to grow at CAGR of 5.4% from 2020 to 2027. Driving factors such as, increasing investments for research in breast cancer management and growing breast cancer prevalence across Asia Pacific...
The Europe breast cancer screening market was valued at US$ 1,231.82 million in 2019 and is projected to reach US$ 1,586.46 million by 2027; it is expected to grow at CAGR of 4.3% from 2020 to 2027. Increasing incidence of breast cancerand presence of prominent players in the breast cancer screening market, as well as robust research and development...
Lung Disease Global Clinical Trials Review, H1, 2020 Summary This clinical trial report, “Lung Disease Global Clinical Trials Review, H1, 2020" provides an overview of Lung Disease Clinical trials scenario.This report provides top line data relating to the clinical trials on Lung Disease. Report...
The major factors driving the growth of the market studied include the rising number of road injuries and joint disorders. There are various bone and joint disorders affecting the body’s musculoskeletal system, which include arthritis, osteoarthritis, rheumatoid arthritis, osteoporosis, and fractures. Arthritis is the leading cause of disability...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.